Burning Rock Biotech
BNR
#8419
Rank
โ‚ฌ0.18 B
Marketcap
17,18ย โ‚ฌ
Share price
-2.68%
Change (1 day)
161.64%
Change (1 year)

Revenue for Burning Rock Biotech (BNR)

Revenue in 2025 (TTM): โ‚ฌ67.59 Million

According to Burning Rock Biotech's latest financial reports the company's current revenue (TTM ) is โ‚ฌ64.13 Million. In 2024 the company made a revenue of โ‚ฌ68.85 Million an increase over the revenue in the year 2023 that were of โ‚ฌ68.64 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Burning Rock Biotech from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ67.59 M-1.82%
2024 โ‚ฌ68.85 M0.31%
2023 โ‚ฌ68.64 M-11.57%
2022 โ‚ฌ77.62 M11.63%
2021 โ‚ฌ69.54 M35.58%
2020 โ‚ฌ51.29 M4.24%
2019 โ‚ฌ49.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OpGen
OPGN
โ‚ฌ4.46 M-93.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ0.60 B 849.65%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ11.82 B 18,333.32%๐Ÿ‡บ๐Ÿ‡ธ USA